TEBIQLI Trademark

Trademark Overview


On Monday, November 5, 2018, a trademark application was filed for TEBIQLI with the United States Patent and Trademark Office. The USPTO has given the TEBIQLI trademark a serial number of 88182280. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 7, 2021. This trademark is owned by Amgen Inc.. The TEBIQLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation
tebiqli

General Information


Serial Number88182280
Word MarkTEBIQLI
Filing DateMonday, November 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 7, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, June 7, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 7, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 29, 2020EXTENSION 2 GRANTED
Thursday, October 29, 2020EXTENSION 2 FILED
Thursday, October 29, 2020TEAS EXTENSION RECEIVED
Thursday, April 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 28, 2020EXTENSION 1 GRANTED
Tuesday, April 28, 2020EXTENSION 1 FILED
Tuesday, April 28, 2020TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 8, 2019ASSIGNED TO LIE
Monday, July 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 25, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, July 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 25, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, July 25, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 13, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, December 13, 2018PRIORITY ACTION E-MAILED
Thursday, December 13, 2018PRIORITY ACTION WRITTEN
Tuesday, December 11, 2018ASSIGNED TO EXAMINER
Tuesday, November 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 8, 2018NEW APPLICATION ENTERED IN TRAM